LD-2 disclosure · 1st Quarter - Termination
AVADEL PHARMACEUTICALS
Income$40Kfee reported
Client
- Description
- Biopharmaceuticals
- Location
- Missouri · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Increased access to narcoleptic medication (S.574/H.R.4692 - Increasing Prescription Drug Competition Act)
LobbyistsJOHN MCMANUS · ALANNA TEMME · ms LAWREN D GEER · ALEX WHALEN
TargetedSENATE · HOUSE OF REPRESENTATIVES